Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4489670 | 0.96 | SMN1; SMN2 (0.65) | SMN1; SMN2TP53TSHRPAOXL3MBTL1 | |
| SCHEMBL1174392 | 0.96 | — | — | |
| SCHEMBL28996592 | 0.88 | SMN1; SMN2 (0.57) | SMN1; SMN2TP53TSHRL3MBTL1ALDH1A1 | |
| SCHEMBL26528338 | 0.88 | PAOX (0.56) | SMN1; SMN2TP53TSHRPAOXL3MBTL1 | |
| SCHEMBL26528341 | 0.88 | SMN1; SMN2 (0.57) | SMN1; SMN2TP53TSHRL3MBTL1ALDH1A1 | |
| SCHEMBL5483874 | 0.87 | SMN1; SMN2 (0.61) | SMN1; SMN2TP53TSHRL3MBTL1ALDH1A1 | |
| SCHEMBL65886 | 0.87 | SMN1; SMN2 (0.61) | SMN1; SMN2TSHRL3MBTL1ALDH1A1KDM4E | |
| SCHEMBL16265631 | 0.87 | SMN1; SMN2 (0.53) | SMN1; SMN2TP53TSHRPAOXL3MBTL1 | |
| SCHEMBL22878472 | 0.86 | SMN1; SMN2 (0.56) | SMN1; SMN2TP53TSHRPAOXL3MBTL1 | |
| SCHEMBL17284723 | 0.86 | SMN1; SMN2 (0.60) | SMN1; SMN2TP53TSHRPAOXL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183616-A1 | NOVEL IONIZABLE LIPIDS AND LIPID NANOPARTICLES AND METHODS OF USING THE SAME | SENDA BIOSCIENCES, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| EP-3145929-B1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS | HOFFMANN LA ROCHE (CH) | 2021-01-13 | — | — | EP | disclosed |
| WO-2019034538-A1 | SYNTHESIS, PHARMACOLOGY AND USE OF NEW AND SELECTIVE FMS-LIKE TYROSINE KINASE 3 (FLT3) FLT3 INHIBITORS | UNIVERSITÄT REGENSBURG (DE) | 2019-02-21 | — | — | WO | disclosed |
| US-20170226132-A1 | TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2017-08-10 | — | — | US | disclosed |
| US-20170145020-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2017-05-25 | — | — | US | disclosed |
| US-9604984-B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | GENENTECH, INC. (US) | 2017-03-28 | — | — | US | disclosed |
| US-20160237086-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2016-08-18 | — | — | US | disclosed |
| US-20160185780-A1 | TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | GENENTECH, INC. (US) | 2016-06-30 | — | — | US | disclosed |
| US-9346815-B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | GENENTECH, INC. (US) | 2016-05-24 | — | — | US | disclosed |
| EP-2403838-B1 | COMPOSITIONS CONTAINING AMIDE SURFACTANTS AND METHODS FOR INHIBITING THE FORMATION OF HYDRATE AGGLOMERATES | NALCO CO (US) | 2016-04-27 | — | — | EP | disclosed |
| US-20100087338-A1 | COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES | US SYNTHETIC CORPORATION | 2010-04-08 | — | — | US | disclosed |
| US-20100087338-A1 | COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES | US SYNTHETIC CORPORATION | 2010-04-08 | — | — | US | disclosed |
| US-20100087339-A1 | COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS | APERGY BMCS ACQUISITION CORP | 2010-04-08 | — | — | US | disclosed |
| US-20100087339-A1 | COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS | APERGY BMCS ACQUISITION CORP | 2010-04-08 | — | — | US | disclosed |
| US-20080200433-A1 | Molecular Chaperone Function Regulator | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20080200433-A1 | Molecular Chaperone Function Regulator | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2008-08-21 | — | — | US | disclosed |
| US-20070265260-A1 | Quinazoline derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-11-15 | — | — | US | disclosed |
| US-20070265260-A1 | Quinazoline derivatives | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2007-11-15 | — | — | US | disclosed |
| US-7294629-B2 | Quinazoline derivatives | MITSUBISHI PHARMA CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
| US-7294629-B2 | Quinazoline derivatives | MITSUBISHI PHARMA CORPORATION (JP) | 2007-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160185780-A1 | TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | ABL1, JAK2, JAK1 | SMN1; SMN2 3249/4885TP53 4346/4885TSHR 2621/4885 |
| US-20100087339-A1 | COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES IN A PROCESS | AQP1, AQP3, AQP4 | SMN1; SMN2 4177/4885TP53 406/4885TSHR 4423/4885 |
| US-20160237086-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | ABL1, JAK2, FLT3 | SMN1; SMN2 3594/4885TP53 735/4885TSHR 3652/4885 |
| US-20100087338-A1 | COMPOSITIONS AND METHODS FOR INHIBITING THE AGGLOMERATION OF HYDRATES | AQP1, AQP3, ABCB7 | SMN1; SMN2 4436/4885TP53 202/4885TSHR 4148/4885 |
| US-20170145020-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS,COMPOSITIONS AND METHODS OF USE THEREOF | ABL1, JAK2, FLT3 | SMN1; SMN2 3594/4885TP53 735/4885TSHR 3652/4885 |
| US-20170226132-A1 | TRIAZOLOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | ABL1, JAK2, JAK1 | SMN1; SMN2 3249/4885TP53 4346/4885TSHR 2621/4885 |
| US-20070265260-A1 | Quinazoline derivatives | TYK2, ROR1, JAK1 | SMN1; SMN2 4784/4885TP53 297/4885TSHR 4548/4885 |
| US-20080200433-A1 | Molecular Chaperone Function Regulator | HSPBP1, HSF1, HSPH1 | SMN1; SMN2 3552/4885TP53 318/4885TSHR 3741/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.